Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Human thymus has stem cells that can self-renew and maintain their identity.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

Abatacept may help some people with alopecia areata regrow hair.

Machine learning can help find new ways to treat alopecia areata.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Overexpressing Merkel cell virus proteins in human hair follicles can create clusters of cells that resemble Merkel cell cancer.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

A new mouse model effectively mimics vitiligo for research and drug testing.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Alopecia areata involves immune response and gene changes affecting hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Certain NK cell changes in blood may indicate alopecia areata progression.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Treg cells help repair and regenerate tissues by interacting with local cells.

Etanercept may not prevent alopecia areata from coming back.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Six months after COVID-19, most patients still had autoantibodies.